Beliefs, experience, and interest in pharmacotherapy among smokers with HIV
Amy McQueen1, Enbal Shacham2, Walton Sumner3
1Washington University School of Medicine, Department of Medicine, Division of Health Behavior Research, St. Louis MO, USA. amcqueen@dom.wustl.edu.
Objectives:
To examine beliefs, prior use, and interest in using pharmacotherapy among people living with HIV/AIDS (PLWHA).
Methods:
Cross-sectional survey of smokers in a midwestern HIV clinic.
Results:
The sample (N = 146) included 69% men, 82% African Americans, 45% were in precontemplation for quitting, and 46% were interested in using pharmacotherapy. Primary reasons for non-use included cost and a belief that they would be able to quit on their own. Physician assistance was the strongest correlate of prior use. Perceived benefits and self-efficacy were the strongest correlates of willingness to use pharmacotherapy.
Conclusions:
Future interventions should address misconceptions, perceived benefits, and self-efficacy for using cessation aids. Physicians should offer pharmacotherapy to all smokers.
More Related Videos
Related Concept Videos
Drug Dependence
The Placebo Effect
Retrovirus Life Cycles
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Affecting Factors
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...


